Works matching IS 00070920 AND DT 2005 AND VI 93 AND IP 2

Results: 16

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells.

Published in:

2005

By:

Wey, J. S.;
Gray, M. J.;
Fan, F.;
Belcheva, A.;
McCarty, M. F.;
Stoeltzing, O.;
Somcio, R.;
Liu, W.;
Evans, D. B.;
Klagsbrun, M.;
Gallick, G. E.;
Ellis, L. M.

Publication type:

journal article

Fertility, gonadal and sexual function in survivors of testicular cancer.

Published in:

2005

By:

Huddart, R. A.;
Norman, A.;
Moynihan, C.;
Horwich, A.;
Parker, C.;
Nicholls, E.;
Dearnaley, D. P.

Publication type:

journal article

T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.

Published in:

2005

By:

Steele, J. C.;
Mann, C. H.;
Rookes, S.;
Rollason, T.;
Murphy, D.;
Freeth, M. G.;
Gallimore, P. H.;
Roberts, S.

Publication type:

journal article

Combined effects of GSTP1 and MRP1 in melanoma drug resistance.

Published in:

2005

By:

Depeille, P.;
Cuq, P.;
Passagne, I.;
Evrard, A.;
Vian, L.

Publication type:

journal article

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

Published in:

2005

By:

Mead, G. M.;
Cullen, M. H.;
Huddart, R.;
Harper, P.;
Rustin, G. J. S.;
Cook, P. A.;
Stenning, S. P.;
Mason, M.;
MRC Testicular Tumour Working Party

Publication type:

journal article

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).

Published in:

2005

By:

Di Costanzo, F.;
Carlini, P.;
Doni, L.;
Massidda, B.;
Mattioli, R.;
Iop, A.;
Barletta, E.;
Moscetti, L.;
Recchia, F.;
Tralongo, P.;
Gasperoni, S.

Publication type:

journal article

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia.

Published in:

2005

By:

Olsen, J. H.;
Hahnemann, J. M. D.;
BØrresen-Dale, A-L.;
Tretli, S.;
Kleinerman, R.;
Sankila, R.;
Hammarstrõm, L.;
Robsahm, T. E.;
Kääriäinen, H.;
Bregard, A;
BrØndum-Nielsen, K.;
Yuen, J.;
Tucker, M.;
Børresen-Dale, A-L;
Hammarström, L;
Kääriäinen, H;
Bregård, A;
Brøndum-Nielsen, K

Publication type:

journal article

p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression.

Published in:

2005

By:

Piaton, E.;
Faÿnel, J.;
Ruffion, A.;
Lopez, J. G.;
Perrin, P.;
Devonec, M.;
Faÿnel, J

Publication type:

journal article

Correction of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinoma.

Published in:

2005

By:

Shannon, A. M.;
Bouchier-Hayes, D. J.;
Condron, C. M.;
Toomey, D.

Publication type:

journal article

Assessing proliferation, cell-cycle arrest and apoptotic end points in human buccal punch biopsies for use as pharmacodynamic biomarkers in drug development.

Published in:

2005

By:

Camidge, D. R.;
Pemberton, M. N.;
Growcott, J. W.;
Johnstone, D.;
Laud, P. J.;
Foster, J. R.;
Randall, K. J.;
Hughes, A. M.

Publication type:

journal article

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.

Published in:

British Journal of Cancer, 2005, v. 93, n. 2, p. 195, doi. 10.1038/sj.bjc.6602687

By:

Ko, A. H.;
Hwang, J.;
Venook, A. P.;
Abbruzzese, J. L.;
Bergsland, E. K.;
Tempero, M. A.

Publication type:

Article

Multiple myeloma and fever of unknown origin: a need for therapy.

Published in:

2005

By:

Mumoli, N;
Cei, M

Publication type:

Letter

Evolving therapeutic role of bisphosphonates in multiple myeloma.

Published in:

2005

By:

Ural, A. U.;
Avcu, F.

Publication type:

Letter

Reply to letters on review ‘Evolving treatment strategies for myeloma’.

Published in:

2005

By:

Morgan, G. J.;
Davies, F. E.

Publication type:

Letter

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.

Published in:

2005

By:

Lordick, F;
Lorenzen, S;
Stollfuss, J;
Vehling-Kaiser, U;
Kullmann, F;
Hentrich, M;
Zumschlinge, R;
Dietzfelbinger, H;
Thoedtmann, J;
Hennig, M;
Seroneit, T;
Bredenkamp, R;
Duyster, J;
Peschel, C

Publication type:

journal article

Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.

Published in:

British Journal of Cancer, 2005, v. 93, n. 2, p. 173, doi. 10.1038/sj.bjc.6602698

By:

Engels, F. K.;
Sparreboom, A.;
Mathot, R. A. A.;
Verweij, J.

Publication type:

Article